Read articles from Global

February 27, 2026 by gfn.tv

GFN.TV Interviews #82 | How Nicotine Pouches Finished What Snus Started?

Sweden’s smoke-free success is often credited to snus, but that’s only half the story. While snus appealed to many men looking to quit smoking, for women the smell, taste, and feel left something to be desired. For years, women were left without a viable alternative. That changed with nicotine pouches. Tobacco-free, discreet, and socially acceptable, they became the missing solution. In this GFN Interviews, Carissa Düring explains why nicotine pouches didn’t just complement the Sweden Model, they completed it, delivering the silver bullet public health refuses to acknowledge.

February 27, 2026 by thecritic.co.uk

Against the vape ban

No sooner had I written last week’s column about how the government is undermining its goal of a “smokefree” England by going to war on vaping than the Department of Health and Social Care (DHSC) announced plans to ban vaping in every publicly accessible building in the land. What are they thinking? To find out, I read DHSC’s Impact Assessment (IA). Impact Assessments were introduced in the 1990s in an attempt to make policy-making “evidence-based” but they soon became a burden on the civil servants who were compelled to turn the vibes-based policies of impulsive politicians into sensible pieces of legislation that balance costs against benefits.

February 25, 2026 by medicalxpress.com

Could a gene lower nicotine dependence? What a CHRNB3 variant suggests

A study in Nature Communications identified a nicotine receptor gene variant linked to lower daily cigarette consumption in Mexican, East Asian, and European populations. Variants in CHRNB3 were found to decrease smoking frequency by 21% to 78%. The study highlights the potential of targeting the β3 subunit for treating nicotine addiction. Further research in larger cohorts is required to fully understand the impact of these genetic variants on smoking dependency. The findings suggest that genetic factors play a role in smoking behavior across different ancestries, indicating potential therapeutic interventions for nicotine addiction.

February 25, 2026 by substack.com

The WHO is a risk-factor for cancer

In a new Code Against Cancer, the World Health Organisation opposes the most effective and popular way to reduce the most important modifiable cancer risk, smoking. So, what does that make WHO?

February 23, 2026 by substack.com

The Updated Meta-Analysis of E-Cigs & Health Outcomes: Still Critically Flawed

Two years ago, tobacco control activist Stanton Glantz and his colleagues published a meta-analysis on e-cigarettes and health outcomes. They systematically reviewed existing studies, grouped them by disease categories such as cardiovascular disease and COPD, and calculated pooled effects for each outcome. However, a meta-analysis is only as reliable as the studies it includes. Most of the underlying papers were based on population survey data that showed correlations between e-cigarette use and nearly every measured health condition. Such correlations are often methodologically weak, as they are prone to confounding and do not establish causation.

February 23, 2026 by euractiv.com

Consumer groups urge Sweden to veto EU nicotine tax overhaul

Campaigners warn EU nicotine tax changes risk smoking setback

February 23, 2026 by gfn.tv

GFN News #178 | IS MEXICO GOING TOO FAR ON VAPING?

In this video, Joanna Junak speaks with Juan José Cirión Lee, president of Mexico y el Mundo Vapeando, about the growing restrictions on vaping in Mexico. They discuss how the new ban impacts harm reduction efforts, limits public access to information, and challenges organizations working to support smokers seeking alternatives. Hear firsthand insights on the future of vaping, public health policy, and advocacy in an increasingly restrictive environment.

February 23, 2026 by scienceline.org

Vaping is less harmful than smoking, experts say. Why don’t smokers know this?

In 2018, Food and Drug Administration launched a public health campaign warning about a so-called vaping epidemic, using shocking imagery to discourage e-cigarette use. Earlier in the 2010s, the FDA focused on harm reduction by encouraging smokers to switch to lower-risk nicotine products such as e-cigarettes. However, when vaping became increasingly popular among teenagers, public health messaging shifted toward discouraging vaping altogether. Anti-vaping campaigns by the government and non-profit organizations appear to have been effective, as the percentage of middle and high school students reporting vaping in the past 30 days dropped significantly from 20% in 2019 to 5.9% in 2024.

February 17, 2026 by springer.com

Nicotine pouches: an aid in smoking cessation, or a new public health hazard?

Tobacco harm reduction strategies are designed to lessen the enormous health burden caused by smoking by offering lower-risk alternatives to people who are unable or unwilling to stop using combustible cigarettes. In recent years, nicotine pouches have emerged as a new category of tobacco-free oral products. Although they are conceptually derived from Swedish snus, they differ by completely eliminating the tobacco leaf, which distinguishes them from traditional smokeless tobacco products.

February 17, 2026 by washingtontimes.com

Harm reduction, not prohibition, right approach to nicotine

As a retired police lieutenant, I’ve seen firsthand how well-intentioned policies often backfire when they ignore basic truths about human behavior. Whether it’s drugs or other public health concerns, the lesson has been the same: When we try to control people’s choices through punishment or sweeping mandates, we often create new harms while failing to address the old ones. That’s why the Food and Drug Administration’s recently announced pilot program to streamline review of nicotine pouch products is a welcome step forward. It reflects a balanced, science-based understanding of the role nicotine pouches play in smoking cessation and public safety.